Based on CMMI's year 1 feedback on OCM, it is clear that a lot of planning is needed and education is crucial, said Terrill Jordan, CEO, of Regional Cancer Care Associates.
Based on CMMI's year 1 feedback on OCM, it is clear that a lot of planning is needed and education is crucial , said Terrill Jordan, CEO, of Regional Cancer Care Associates.
Transcript (slightly modified)
What are some insights that you have drawn from the year I feedback from CMMI on OCM?
It’s a lot of work; that’s the main thing we’ve learned. There’s a lot of organization that goes into this; you have a lot of planning. Given when it started, and the amount of time we had to get everything in place, we found that we couldn’t do enough panning. So that was the main thing. The other is education. You have to educate, educate, educate. So our team is focused on how do we educate our clinicians, how do we educate their staff, how do we educate even our own team about what these programs are about and how you implement them. It’s a complete change in how you practice.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More